UnitedHealth (UNH) has begun hiring allies of President Donald Trump and is trying to plead its case to top officials in his administration as the company faces more government investigations and changes in federal payments, Josh Dawsey, Christopher Weaver, and Anna Wilde Mathews of The Wall Street Journal reports. After being faces with a criminal investigation into its key Medicare business, UnitedHealth met with senior Justice Department officials to discuss probes of the company, people familiar with the meeting told the Journal. Additionally, CEO Stephen Hemsley recently met with White House chief of staff to discuss Medicare and other issues, a White House official said.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth’s Stock Soars Amid Medicare Optimism
- Top Morgan Stanley Analyst Lifts UnitedHealth Stock (UNH) Price Target. Here’s Why
- UnitedHealth price target raised to $395 from $325 at Morgan Stanley
- Morgan Stanley Beats the Drum for UnitedHealth (UNH) Stock — But Can It Climb Higher?
- UnitedHealth (UNH) Stock Wins a Price Target Boost from Top UBS Analyst